Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019
A Barlow, KM Landolf, B Barlow… - … : The Journal of …, 2020 - Wiley Online Library
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …
COVID-19: A review of the proposed pharmacological treatments
S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
Pharmacological treatments of COVID-19
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …
which was reported for the first time in December 2019, was named by the World Health …
Medical treatment options for COVID-19
Therapeutic options for coronavirus disease 2019 are desperately needed to respond to the
ongoing severe acute respiratory syndrome coronavirus 2 pandemic. Both antiviral drugs …
ongoing severe acute respiratory syndrome coronavirus 2 pandemic. Both antiviral drugs …
An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
Drugs for COVID-19: An update
J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
Advances in the possible treatment of COVID-19: A review.
P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review
JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell - Jama, 2020 - jamanetwork.com
Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …
Coronavirus disease 2019 treatment: a review of early and emerging options
EK McCreary, JM Pogue - Open forum infectious diseases, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …
The rationale for potential pharmacotherapy of COVID-19
On 11 March 2020, the coronavirus disease (COVID-19) was defined by the World Health
Organization as a pandemic. Severe acute respiratory syndrome-2 (SARS-CoV-2) is the …
Organization as a pandemic. Severe acute respiratory syndrome-2 (SARS-CoV-2) is the …